Thyroid autoimmunity disorders during interferon β-1b treatment in patients with multiple sclerosis: Review and case report;Autoimmune funktionsstörungen der schilddrüse unter interferon-β-1b-therapie bei patienten mit multipler sklerose: Kasuistik und literaturübersicht

Nervenarzt

Volumn 75, Issue 6, 2004, Pages 589-594

  Lange Asschenfeldt, C ^a,b   Boor, S ^a   Kahaly, G J ^a   Thomke F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Autoimmunity; Interferon 1b; Multiple sclerosis; Thyroid disorder

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE;

ADULT; AUTOIMMUNE DISEASE; CASE REPORT; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOMODULATION; MULTIPLE SCLEROSIS; REVIEW; RISK FACTOR; VIRUS HEPATITIS;

ADULT; AUTOIMMUNE DISEASES; FEMALE; GRAVES DISEASE; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; TREATMENT OUTCOME;

EID: 3042845255     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Annunziata P, Lore F, Venturini E, Morana P, Guarino E, Borghi S, Guazzi GC (1999) Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis. J Neurol Sci 168: 32-36
2. Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G (2001) Long-term outcome of interferon-α- induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 86: 1925-1929
3. Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G (1999) Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci 162: 74-83
4. Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M (2001) Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS. Neurology 57: 1363-1370
5. Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, Zaffaroni M (2001) Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab 86: 3525-3532
6. Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, Bergamasco B, Brossa PC, Ghigo E, Maccario M, Faggiano F (2001) Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci 193: 17-22
7. Kahaly GJ (2001) Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 145: 107-118
8. Karni A, Abramsky O (1999) Association of MS with thyroid disorders. Neurology S3: 883-88S
9. Kreisler A, Seze J de, Stojkovic T, Delisse B, Combelles M, Vérier A, Hautecoeur P, Vermersch P (2003) Multiple sclerosis, interferon beta and clinical thyroid dysfunction. Acta Neurol Scand 107: 1S4-1S7
10. Martinelli V, Gironi M, Rodegher M, Martino G, Comi G (1998) Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment. Ital J Neurol Sci 19: 65-67
11. Monzani F, Caraccio N, Meucci G, Lombardo F, Moscato G, Casolaro A, Ferdeghini M, Murri L, Ferrannini E (1999) Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis. Eur J Endocrinol 141: 325-331
12. Monzani F, Caraccio N, Casolaro A, Lombardo F, Moscato G, Murri L, Ferrannini E, Meucci G (2000) Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful? Neurology 55: 549-552
13. Monzani F, Meucci G, Caraccio N, Saviozzi M, Casolaro A, Moscato G, Lombardo F, Mosti S, Scagnolari C, Bruschi F, Antonelli G, Ferrannini E, Murri L (2002) Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis. J Interferon Cytokine Res 22: 773-781
14. Niederwieser G, Buchinger W, Monelli RM, Berghold A, Reisecker F, Koltringer P, Archelos JJ (2003) Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250: 672-675
15. Rotondi M, Oliviero A, Profice P, Mone CM, Biondi B, Del Buono A, Mazziotti G, Sinisi AM, Bellastella A, Carella C (1998) Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. J Endocrinol Invest 21: 748-752
16. Rotondi M, Mazziotti G, Biondi B, Manganella G, Del Buono AD, Montella P, Cristofaro M di, Di Iorio G, Amato G, Carella C (2000) Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. J Endocrinol Invest 23: 321-324
17. Schwid SR, Goodman AD, Mattson DH (1997) Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch Neurol 54: 1169-1190
18. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH (1990) American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 263: 1529-1532
19. Tourbah A, Clapin A, Gout O, Fontaine B, Liblau R, Batteux F, Stievenart JL, Weill B, Lubetzki C, Lyon-Caen O (1998) Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol 55: 517-521
20. Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L (2002) Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases? J Interferon Cytokine Res 22: 245-255
21. Weetman AP, McGregor AM (1994) Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15: 788-830